z-logo
open-access-imgOpen Access
Prevalence and predictors of injecting‐related injury and disease among clients of Australia's needle and syringe programs
Author(s) -
Topp Libby,
Iversen Jenny,
Conroy Andrew,
Salmon Allison M.,
Maher Lisa
Publication year - 2008
Publication title -
australian and new zealand journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.946
H-Index - 76
eISSN - 1753-6405
pISSN - 1326-0200
DOI - 10.1111/j.1753-6405.2008.00163.x
Subject(s) - medicine , serostatus , syringe , emergency medicine , family medicine , psychiatry , human immunodeficiency virus (hiv) , viral load
Objective:To identify lifetime prevalence and predictors of self‐reported injecting‐related injuries and diseases (IRID) and/or injecting‐related problems (IRP) among a national cross‐sectional sample of injecting drug users.Methods:1,961 clients of 45 needle and syringe programs (NSPs) who participated in the 2006 Australian NSP Survey self‐completed an item regarding lifetime experience of eight separate IRIDs and IRPs.Results:Sixty‐nine per cent of participants reported a history of IRID/IRP, with a mean of 1.9 injuries/problems (range 0‐8). Lifetime prevalence of specific injuries/problems ranged from problems finding a vein (43%) to endocarditis (4%). Factors independently associated with IRID/IRP included bisexual identity; daily or more frequent injecting; injection of pharmaceutical preparations; female gender; longer injecting history; and hepatitis C antibody‐positive serostatus.Conclusions:Consistent with existing literature, results suggest that vascular injury and localised infections are common among IDUs; and that treatment‐seeking is often delayed until serious complications arise.Implications:Findings support the imperative for co‐ordinated and timely treatment and prevention activities to reduce the severity and burden of these prevalent injecting outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here